FR2042333A1 - - Google Patents

Info

Publication number
FR2042333A1
FR2042333A1 FR7013609A FR7013609A FR2042333A1 FR 2042333 A1 FR2042333 A1 FR 2042333A1 FR 7013609 A FR7013609 A FR 7013609A FR 7013609 A FR7013609 A FR 7013609A FR 2042333 A1 FR2042333 A1 FR 2042333A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7013609A
Other languages
French (fr)
Other versions
FR2042333B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2990569A external-priority patent/JPS5010298B1/ja
Priority claimed from JP2990769A external-priority patent/JPS5010299B1/ja
Priority claimed from JP8004269A external-priority patent/JPS5010308B1/ja
Priority claimed from JP10419469A external-priority patent/JPS4939995B1/ja
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of FR2042333A1 publication Critical patent/FR2042333A1/fr
Priority claimed from US00206966A external-priority patent/US3821404A/en
Application granted granted Critical
Publication of FR2042333B1 publication Critical patent/FR2042333B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR707013609A 1969-04-16 1970-04-15 Expired FR2042333B1 (enExample)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP2990569A JPS5010298B1 (enExample) 1969-04-16 1969-04-16
JP2990769A JPS5010299B1 (enExample) 1969-04-16 1969-04-16
JP3416769 1969-05-02
JP3416669 1969-05-02
JP8004269A JPS5010308B1 (enExample) 1969-10-03 1969-10-03
JP8004169 1969-10-03
JP10280969 1969-12-19
JP10419469A JPS4939995B1 (enExample) 1969-12-23 1969-12-23
US2641270A 1970-04-07 1970-04-07
US00206966A US3821404A (en) 1969-04-16 1971-12-10 Phenoxy carboxylic acid derivatives as anti-atherosclerosis agents

Publications (2)

Publication Number Publication Date
FR2042333A1 true FR2042333A1 (enExample) 1971-02-12
FR2042333B1 FR2042333B1 (enExample) 1973-04-06

Family

ID=27579824

Family Applications (1)

Application Number Title Priority Date Filing Date
FR707013609A Expired FR2042333B1 (enExample) 1969-04-16 1970-04-15

Country Status (9)

Country Link
US (2) US3716583A (enExample)
AT (2) AT302278B (enExample)
BE (1) BE748970A (enExample)
CA (1) CA964273A (enExample)
CH (2) CH539012A (enExample)
DK (1) DK128731B (enExample)
FI (1) FI52570C (enExample)
FR (1) FR2042333B1 (enExample)
NL (1) NL139016B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2193592A1 (enExample) * 1972-07-20 1974-02-22 Sumitomo Chemical Co
FR2235680A1 (enExample) * 1973-07-02 1975-01-31 Sumitomo Chemical Co

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092324A (en) * 1971-05-22 1978-05-30 Sumitomo Chemical Company, Limited Diheterocyclic esters of 4-(1,1-bis-(phenoxy-propionic or -butoyric acid)-cyclohexane)α-methyl substituted
US4008265A (en) * 1971-05-22 1977-02-15 Sumitomo Chemical Company, Limited Novel bisphenoxy carboxylic acid derivatives and their salts
JPS575214B2 (enExample) * 1972-06-01 1982-01-29
CH617417A5 (enExample) * 1973-12-27 1980-05-30 Siegfried Ag
AT353776B (de) * 1973-12-27 1979-12-10 Siegfried Ag Verfahren zur herstellung von neuen alkan- saeuren, deren estern und salzen
FR2428629A1 (fr) * 1978-06-14 1980-01-11 Hexachimie Nouveaux composes bis(aryloxycarboxyliques), leur preparation et leur utilisation en therapeutique
EP0363760A1 (de) * 1988-10-12 1990-04-18 Bayer Ag Aromatische Ether
US5179097A (en) * 1991-06-10 1993-01-12 Angres Isaac A Salts of non-steroidal anti-inflammatory carboxylic acids and anti-lipidemic carboxylic acids
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
EP1911462A3 (en) 2001-01-26 2011-11-30 Schering Corporation Compositions comprising a sterol absorption inhibitor
KR20070120617A (ko) * 2001-01-26 2007-12-24 쉐링 코포레이션 치환된 아제티딘온 화합물을 포함하는 약제학적 조성물
MXPA03006727A (es) * 2001-01-26 2003-10-24 Schering Corp Combinaciones de acido nicotinico y derivados del mismo con inhibidor(es) de la absorcion de los esteroles, y tratamiento para indicaciones vasculares.
EP1413331B1 (en) * 2001-01-26 2007-10-03 Schering Corporation Combinations of the peroxisome proliferator-activated receptor (PPAR) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications
DK1385548T3 (da) * 2001-01-26 2007-09-10 Schering Corp Kombinationer af sterolabsorptionsinhibitor(er) med (et eller flere) kardiovaskulære midler til behandling af vaskulære tilstande
KR20040025890A (ko) * 2001-01-26 2004-03-26 쉐링 코포레이션 혈관성 질환을 치료하기 위한 스테롤 흡수 억제제와 혈액조절제의 조합물
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
EP1785144A3 (en) * 2001-01-26 2007-05-23 Shering Corporation Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
ATE345792T1 (de) * 2001-05-25 2006-12-15 Schering Corp Verwendung von mit azetidinon substituierten derivaten bei der behandlung der alzheimer- krankheit
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
DE60216300T2 (de) * 2001-09-21 2007-06-28 Schering Corp. Behandlung von xanthom mittels azetidinon-derivate als hemmer der sterol absorption
NZ531060A (en) * 2001-09-21 2006-06-30 Schering Corp Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
CA2504916A1 (en) * 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
CA2517573C (en) * 2003-03-07 2011-12-06 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
MXPA05009503A (es) * 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
DE602004018617D1 (de) * 2003-03-07 2009-02-05 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
MXPA05012900A (es) * 2003-05-30 2006-02-22 Ranbaxy Lab Ltd Derivados de pirrol sustituidos.
JP2007510659A (ja) * 2003-11-05 2007-04-26 シェーリング　コーポレイション 脂質調節剤および置換アゼチジノンの組み合わせならびに血管状態の処置
US6998397B2 (en) * 2004-07-23 2006-02-14 Drebsk Comptech, Inc. Method for decreasing cholesterol level in blood
KR101329112B1 (ko) * 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
EP2049102A4 (en) * 2006-07-14 2010-12-22 Ranbaxy Lab Ltd POLYMORPHIC FORMS OF AN HMG COA REDUCTASE HEATHER AND USE
EP2134169A2 (en) 2007-03-09 2009-12-23 Indigene Pharmaceuticals Inc. Combination of metformin r-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
CR20170356A (es) 2015-02-06 2018-02-28 Intercept Pharmaceuticals Inc Composiciones farmacéuticas para terapia combinada
CN104610051A (zh) * 2015-03-02 2015-05-13 北京万全德众医药生物技术有限公司 一种制备克利贝特杂质的方法
KR20220016146A (ko) 2019-05-30 2022-02-08 인터셉트 파마슈티컬즈, 인크. 담즙정체성 간 질환의 치료에서 사용하기 위한 fxr 효능제 및 피브레이트를 포함하는 제약 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB970969A (en) * 1963-08-15 1964-09-23 Shell Int Research Dicarboxylic acids and their esters and a process for the preparation thereof
FR1380816A (fr) * 1963-11-18 1964-12-04 Ciba Geigy Procédé de préparation de nouveaux acides isobutyriques, entre autres de l'acide alpha-[p-(2-p'-chlorophényl-propyl-[2])-phénoxy]-isobutyrique

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2444594A (en) * 1947-08-07 1948-07-06 American Cyanamid Co Isopropylidene-p-phenoxy-2-ethanol-p-phenoxyacetic acid
US2541003A (en) * 1948-08-17 1951-02-06 American Cyanamid Co Process for reacting salts of phenols with halo-alkanoic acid compounds
GB860303A (en) * 1958-06-20 1961-02-01 Ici Ltd Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª
US3169144A (en) * 1960-08-12 1965-02-09 Massarani Elena Anticholesterinemic and antilipaemic agents
US3470234A (en) * 1965-08-23 1969-09-30 Ciba Geigy Corp Diaryl substituted benzocycloalkanes
US3470235A (en) * 1965-11-05 1969-09-30 Eastman Kodak Co Alicyclic bisphenyleneoxydicarboxylic acids,salts and esters
GB1121722A (en) * 1966-03-31 1968-07-31 Ici Ltd New carboxylic acid derivatives
US3630715A (en) * 1968-12-19 1971-12-28 Weston Chemical Corp Alkylene bis (phenoxyacetic acid) derivatives as herbicides
US3755603A (en) * 1970-07-01 1973-08-28 Syntex Corp Biphenylyloxyacetic acids in pharmaceutical compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB970969A (en) * 1963-08-15 1964-09-23 Shell Int Research Dicarboxylic acids and their esters and a process for the preparation thereof
FR1380816A (fr) * 1963-11-18 1964-12-04 Ciba Geigy Procédé de préparation de nouveaux acides isobutyriques, entre autres de l'acide alpha-[p-(2-p'-chlorophényl-propyl-[2])-phénoxy]-isobutyrique

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2193592A1 (enExample) * 1972-07-20 1974-02-22 Sumitomo Chemical Co
FR2235680A1 (enExample) * 1973-07-02 1975-01-31 Sumitomo Chemical Co

Also Published As

Publication number Publication date
US3959484A (en) 1976-05-25
NL7005400A (enExample) 1970-10-20
FI52570B (enExample) 1977-06-30
CH556807A (de) 1974-12-13
AT303015B (de) 1972-11-10
CA964273A (en) 1975-03-11
CH539012A (de) 1973-08-31
US3716583A (en) 1973-02-13
NL139016B (nl) 1973-06-15
FR2042333B1 (enExample) 1973-04-06
AT302278B (de) 1972-10-10
BE748970A (fr) 1970-09-16
DK128731B (da) 1974-06-24
FI52570C (fi) 1977-10-10

Similar Documents

Publication Publication Date Title
FI52570B (enExample)
AU465452B2 (enExample)
AU450150B2 (enExample)
AU442375B2 (enExample)
CS152382B2 (enExample)
CS154668B2 (enExample)
AU470301B1 (enExample)
AU442554B2 (enExample)
AU442357B2 (enExample)
AU414607B2 (enExample)
AU442535B2 (enExample)
AU442463B2 (enExample)
AU442380B2 (enExample)
AU442322B2 (enExample)
AU470661B1 (enExample)
AU442285B2 (enExample)
AU5228269A (enExample)
AU5397469A (enExample)
CS150728B1 (enExample)
AU5077469A (enExample)
AU4949169A (enExample)
AU5109569A (enExample)
AU5598769A (enExample)
AU5979569A (enExample)
AU5960768A (enExample)